New high-cost cell-based gene therapy drug Encelto approved for use in the ambulatory surgical center (ASC) setting
Medicare approved the groundbreaking new cell-based gene therapy drug, Encelto, for use in the ambulatory surgical center...
Medicare approved the groundbreaking new cell-based gene therapy drug, Encelto, for use in the ambulatory surgical center...
Avoid negative impacts to your claims by providing the medical records for the laboratory, pathology and other codes claims...
Use this article as a quick reference for billing claims where Medicare is the secondary payer.
Read this article for more information on how to bill claims when Medicare is the secondary payer.
This article will assist Medicare Part A providers with proper billing relating to COVID-19 vaccine and monoclonal antibody...
Read this article for information on vaccine fees for calendar year 2025.
View annual deductibles and coinsurance for beneficiaries covered through the Medicare fee-for-service program.
This is an article about diagnostic testing for sleep disorders.
Effective July 1, 2026, new billing instructions apply related to no longer submitting the AX modifier and hemodiafiltration and...
Read this article to learn more about radioactive diagnostic agents for positron emission tomography of prostate-specific...